跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 536,216 条关于
“Cumming School of Medicine”
全部
536,216
临床试验
487,156
药物
4,702
机构
3,567
资讯
40,791
去年
Arch Biopartners Acquires Novel IL-32 Platform for Chronic Kidney Disease Treatment
2年前
Arch Biopartners Receives Ethics Approval for Phase II Trial of LSALT Peptide in Calgary
2个月前
First-in-Class CAR T Therapy GCAR1 Shows Early Promise Against Treatment-Resistant Solid Tumors
去年
Arch Biopartners Initiates Phase II Trial of LSALT Peptide for Cardiac Surgery-Associated Acute Kidney Injury
去年
Arch Biopartners Doses First Patient in Canada for Phase II Trial of LSALT Peptide in Cardiac Surgery-Associated Acute Kidney Injury
去年
Arch Biopartners Doses First Patient in Phase II Trial for Cardiac Surgery-Associated Acute Kidney Injury
2年前
Arch Biopartners' LSALT Peptide Phase II Trial Approved for Cardiac Surgery-Associated Acute Kidney Injury
2个月前
AI in Healthcare Risks Encoding and Amplifying Health Inequities, Experts Warn
11个月前
PV-10 Shows Promise as Novel STING-Pathway Vaccine Adjuvant in University of Calgary Research
6个月前
Avicanna Launches Phase I Clinical Trial to Determine Optimal THC Dosing for Anxiety Treatment
第 1 页，共 4080 页
上一页
下一页
